These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 25104521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I, Mohammed SF, Forfia PR, Lewis GD, Borlaug BA, Gallup DS, Redfield MM.
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
    Borlaug BA, Lewis GD, McNulty SE, Semigran MJ, LeWinter M, Chen H, Lin G, Deswal A, Margulies KB, Redfield MM.
    Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
    [Abstract] [Full Text] [Related]

  • 8. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
    AbouEzzeddine OF, Haines P, Stevens S, Nativi-Nicolau J, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM.
    JACC Heart Fail; 2015 Mar; 3(3):245-52. PubMed ID: 25742762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial.
    Wang H, Anstrom K, Ilkayeva O, Muehlbauer MJ, Bain JR, McNulty S, Newgard CB, Kraus WE, Hernandez A, Felker GM, Redfield M, Shah SH.
    JAMA Cardiol; 2017 Aug 01; 2(8):896-901. PubMed ID: 28492915
    [Abstract] [Full Text] [Related]

  • 14. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
    Guazzi M, Vicenzi M, Arena R, Guazzi MD.
    Circ Heart Fail; 2011 Jan 01; 4(1):8-17. PubMed ID: 21036891
    [Abstract] [Full Text] [Related]

  • 15. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA.
    Circulation; 2017 Jul 04; 136(1):6-19. PubMed ID: 28381470
    [Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
    Belyavskiy E, Ovchinnikov A, Potekhina A, Ageev F, Edelmann F.
    BMC Cardiovasc Disord; 2020 Sep 10; 20(1):408. PubMed ID: 32912157
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction.
    Alogna A, Koepp KE, Sabbah M, Espindola Netto JM, Jensen MD, Kirkland JL, Lam CSP, Obokata M, Petrie MC, Ridker PM, Sorimachi H, Tchkonia T, Voors A, Redfield MM, Borlaug BA.
    JACC Heart Fail; 2023 Nov 10; 11(11):1549-1561. PubMed ID: 37565977
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
    Liu LC, Hummel YM, van der Meer P, Berger RM, Damman K, van Veldhuisen DJ, Voors AA, Hoendermis ES.
    Eur J Heart Fail; 2017 Jan 10; 19(1):116-125. PubMed ID: 27873388
    [Abstract] [Full Text] [Related]

  • 20. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD, PARAMOUNT Investigators.
    J Am Coll Cardiol; 2014 Feb 11; 63(5):447-56. PubMed ID: 24184245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.